DK3191466T3 - Azetidinyloxyphenylpyrrolidinforbindelser - Google Patents

Azetidinyloxyphenylpyrrolidinforbindelser Download PDF

Info

Publication number: DK3191466T3
Authority: DK; Denmark
Prior art keywords: azetidinyloxyphenylpyrrolidine compounds; azetidinyloxyphenylpyrrolidine; compounds
Prior art date: 2014-09-12

Application number

DK15763763.8T

Other languages

English (en)

Inventor

Gary G Deng

Danwen Huang

Cynthia Darshini Jesudason

Joshua O Odingo

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-09-12

Filing date

2015-09-03

Publication date

2020-01-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54140711&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3191466(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-09-03 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2020-01-20 Application granted granted Critical

2020-01-20 Publication of DK3191466T3 publication Critical patent/DK3191466T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK15763763.8T 2014-09-12 2015-09-03 Azetidinyloxyphenylpyrrolidinforbindelser DK3191466T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201462049485P	2014-09-12	2014-09-12
PCT/US2015/048267 WO2016040083A1 (en)	2014-09-12	2015-09-03	Azetidinyloxyphenylpyrrolidine compounds

Publications (1)

Publication Number	Publication Date
DK3191466T3 true DK3191466T3 (da)	2020-01-20

Family

ID=54140711

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK15763763.8T DK3191466T3 (da)	2014-09-12	2015-09-03	Azetidinyloxyphenylpyrrolidinforbindelser

Country Status (34)

Country	Link
US (2)	US10781202B2 (da)
EP (1)	EP3191466B1 (da)
JP (1)	JP6285610B2 (da)
KR (1)	KR101857931B1 (da)
CN (1)	CN106795137B (da)
AP (1)	AP2017009778A0 (da)
AR (1)	AR101696A1 (da)
AU (1)	AU2015315533B2 (da)
BR (1)	BR112017002852A2 (da)
CA (1)	CA2955634A1 (da)
CL (1)	CL2017000484A1 (da)
CO (1)	CO2017001389A2 (da)
CR (1)	CR20170050A (da)
DK (1)	DK3191466T3 (da)
EA (1)	EA030034B1 (da)
EC (1)	ECSP17014972A (da)
ES (1)	ES2770047T3 (da)
HR (1)	HRP20200119T1 (da)
HU (1)	HUE047551T2 (da)
IL (1)	IL250378A0 (da)
LT (1)	LT3191466T (da)
MX (1)	MX2017003138A (da)
NZ (1)	NZ729087A (da)
PE (1)	PE20170328A1 (da)
PH (1)	PH12017500459A1 (da)
PL (1)	PL3191466T3 (da)
PT (1)	PT3191466T (da)
RS (1)	RS59845B1 (da)
SG (1)	SG11201701225YA (da)
SI (1)	SI3191466T1 (da)
TN (1)	TN2017000047A1 (da)
TW (1)	TW201625591A (da)
WO (1)	WO2016040083A1 (da)
ZA (1)	ZA201700555B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK2970283T3 (da)	2013-03-14	2021-01-25	Boehringer Ingelheim Int	Substituerede 2-aza-bicyclo[2.2.1]heptan-3-carboxylsyre-(benzyl-cyano-methyl)-amider som inhibitorer af cathepsin-c
KR102510588B1 (ko)	2014-09-12	2023-03-17	베링거 인겔하임 인터내셔날 게엠베하	카텝신 c의 스피로사이클릭 억제제
AU2019408336B2 (en) *	2018-12-18	2022-03-10	Wuhan Humanwell Innovative Drug Research and Development Center Limited Company	Phenylpyrrolidine compound and use thereof
CN111333637B (zh) *	2018-12-18	2022-07-29	武汉人福创新药物研发中心有限公司	苯基吡咯烷类衍生物及其制备方法
CN111333625B (zh) *	2018-12-18	2022-10-18	武汉人福创新药物研发中心有限公司	苯基吡咯烷类化合物及其用途
CN112409333B (zh) *	2019-08-23	2024-06-14	武汉人福创新药物研发中心有限公司	苯基吡咯烷类化合物
TW202302587A (zh)	2021-04-29	2023-01-16	大陸商蘇州盛迪亞生物醫藥有限公司	異喹啉酮類化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6258833B1 (en)	1999-12-23	2001-07-10	Icos Corporation	Cyclic AMP-specific phosphodiesterase inhibitors
CA2436551A1 (en) *	2001-01-31	2002-08-08	Pfizer Products Inc.	Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
WO2007039075A2 (en)	2005-09-29	2007-04-12	Bayer Healthcare Ag	Pde inhibitors and combinations thereof for the treatment of urological disorders
TW201206440A (en)	2010-04-28	2012-02-16	Astellas Pharma Inc	Prophylactic or therapeutic agent for diseases associated with pains in urinary organs
JO3264B1 (ar)	2013-03-13	2018-09-16	Lilly Co Eli	مركبات ازيتيدينيل أوكسي فينيل بيروليدين
WO2016033776A1 (en) *	2014-09-04	2016-03-10	Eli Lilly And Company	Crystalline (2s) -3- [ (3s, 4s) -3- [ (1r) -1-hydroxyethyl] -4- (4-methoxy-3- { [1- (5-methylpyridin-2-yl) azetidin-3-yl] oxy} phenyl) -3-methylpyrrolidin-1-yl] -3-oxopropane-1, 2-diol

2015
- 2015-08-26 AR ARP150102734A patent/AR101696A1/es unknown
- 2015-08-26 TW TW104127990A patent/TW201625591A/zh unknown
- 2015-09-03 DK DK15763763.8T patent/DK3191466T3/da active
- 2015-09-03 NZ NZ729087A patent/NZ729087A/en not_active IP Right Cessation
- 2015-09-03 CN CN201580046264.3A patent/CN106795137B/zh active Active
- 2015-09-03 WO PCT/US2015/048267 patent/WO2016040083A1/en not_active Ceased
- 2015-09-03 PE PE2017000243A patent/PE20170328A1/es unknown
- 2015-09-03 EP EP15763763.8A patent/EP3191466B1/en active Active
- 2015-09-03 ES ES15763763T patent/ES2770047T3/es active Active
- 2015-09-03 JP JP2017513639A patent/JP6285610B2/ja active Active
- 2015-09-03 EA EA201790156A patent/EA030034B1/ru not_active IP Right Cessation
- 2015-09-03 SI SI201531038T patent/SI3191466T1/sl unknown
- 2015-09-03 PL PL15763763T patent/PL3191466T3/pl unknown
- 2015-09-03 LT LTEP15763763.8T patent/LT3191466T/lt unknown
- 2015-09-03 MX MX2017003138A patent/MX2017003138A/es unknown
- 2015-09-03 TN TN2017000047A patent/TN2017000047A1/en unknown
- 2015-09-03 BR BR112017002852A patent/BR112017002852A2/pt not_active Application Discontinuation
- 2015-09-03 RS RS20200096A patent/RS59845B1/sr unknown
- 2015-09-03 US US15/506,017 patent/US10781202B2/en active Active
- 2015-09-03 CR CR20170050A patent/CR20170050A/es unknown
- 2015-09-03 PT PT157637638T patent/PT3191466T/pt unknown
- 2015-09-03 HR HRP20200119TT patent/HRP20200119T1/hr unknown
- 2015-09-03 AU AU2015315533A patent/AU2015315533B2/en not_active Ceased
- 2015-09-03 AP AP2017009778A patent/AP2017009778A0/en unknown
- 2015-09-03 SG SG11201701225YA patent/SG11201701225YA/en unknown
- 2015-09-03 CA CA2955634A patent/CA2955634A1/en not_active Abandoned
- 2015-09-03 KR KR1020177006717A patent/KR101857931B1/ko not_active Expired - Fee Related
- 2015-09-03 HU HUE15763763A patent/HUE047551T2/hu unknown
2017
- 2017-01-24 ZA ZA2017/00555A patent/ZA201700555B/en unknown
- 2017-01-31 IL IL250378A patent/IL250378A0/en unknown
- 2017-02-13 CO CONC2017/0001389A patent/CO2017001389A2/es unknown
- 2017-03-01 CL CL2017000484A patent/CL2017000484A1/es unknown
- 2017-03-10 PH PH12017500459A patent/PH12017500459A1/en unknown
- 2017-03-14 EC ECIEPI201714972A patent/ECSP17014972A/es unknown
2019
- 2019-09-13 US US16/570,422 patent/US20200002318A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CR20170050A (es)	2017-04-25
AR101696A1 (es)	2017-01-04
ES2770047T3 (es)	2020-06-30
KR101857931B1 (ko)	2018-05-14
IL250378A0 (en)	2017-03-30
US20200002318A1 (en)	2020-01-02
ECSP17014972A (es)	2018-03-31
US20170240532A1 (en)	2017-08-24
AU2015315533B2 (en)	2018-03-15
CL2017000484A1 (es)	2017-11-10
EA030034B1 (ru)	2018-06-29
TN2017000047A1 (en)	2018-07-04
EP3191466A1 (en)	2017-07-19
NZ729087A (en)	2018-07-27
HUE047551T2 (hu)	2020-04-28
SG11201701225YA (en)	2017-03-30
AP2017009778A0 (en)	2017-03-31
LT3191466T (lt)	2020-02-25
TW201625591A (zh)	2016-07-16
JP2017527587A (ja)	2017-09-21
US10781202B2 (en)	2020-09-22
MX2017003138A (es)	2017-05-23
EP3191466B1 (en)	2019-12-04
EA201790156A1 (ru)	2017-06-30
JP6285610B2 (ja)	2018-02-28
CA2955634A1 (en)	2016-03-17
PL3191466T3 (pl)	2020-05-18
AU2015315533A1 (en)	2017-02-23
SI3191466T1 (sl)	2020-02-28
RS59845B1 (sr)	2020-02-28
CN106795137A (zh)	2017-05-31
CO2017001389A2 (es)	2017-05-10
PE20170328A1 (es)	2017-04-19
WO2016040083A1 (en)	2016-03-17
PH12017500459A1 (en)	2017-07-31
ZA201700555B (en)	2018-12-19
HRP20200119T1 (hr)	2020-04-03
KR20170040803A (ko)	2017-04-13
CN106795137B (zh)	2020-08-25
PT3191466T (pt)	2020-02-17
BR112017002852A2 (pt)	2017-12-26

Publication	Publication Date	Title
LT3134402T (lt)	2020-07-10	4-amino-imidazochinolino junginiai
LT3197883T (lt)	2020-07-10	Nauji junginiai
DK3183051T3 (da)	2020-06-02	Væske-til-luftmembranenergivekslere
DK3006072T3 (da)	2021-10-25	Karadgang
DK3211743T3 (da)	2019-12-16	Ø-til-netværk-omskiftningsfremgangsmåde
DK3222714T3 (da)	2019-12-09	Phytasemutanter
DK3119396T3 (da)	2021-05-31	Muscarinreceptoragonister
EP3230438C0 (en)	2024-12-04	N-GLYCOSYLATION
BR112016030730A2 (pt)	2017-08-22	Composto
DK3183340T3 (da)	2019-08-19	Termolabile exonukleaser
EP4011484C0 (en)	2025-09-24	CARBONIC ANHYDRASE OF THERMOVIBRIO AMMONIFICANS
DE112015001664A5 (de)	2016-12-29	Betätigungsaktuator
CL2016002165A1 (es)	2017-06-09	Compuestos de aminocarbonilcarbamato
DK3191466T3 (da)	2020-01-20	Azetidinyloxyphenylpyrrolidinforbindelser
DE112015005041A5 (de)	2017-08-31	Gargerätevorrichtung
DK3154703T3 (da)	2020-11-16	Fuldkappe-snekkecentrifuge
DK3110439T3 (da)	2019-05-13	Pcsk9-vacciner
DE102014000623A8 (de)	2016-10-13	Halbhohlnietelement
HUE039805T2 (hu)	2019-02-28	Új szulfonilaminobenzamid vegyületek
DK3009858T3 (da)	2021-08-09	Skyradar
BR112016027901A2 (pt)	2017-08-22	Compostos
DE112015001633A5 (de)	2017-02-23	Betätigungsaktuator
DK3447493T3 (da)	2020-08-17	Proteinrettede ortologer
ES1133830Y (es)	2015-02-12	Columbario
DE202014005655U8 (de)	2014-11-13	llluminationsvorrichtung